Nancie Latson

New First-Line Option for Advanced ALK-Positive Lung Cancer

December 18, 2024

Oncology/Hematology > Lung Cancer — In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor by Mike Bassett, Staff Writer,...

Nancie Latson

New First-Line Option for Advanced ALK-Positive Lung Cancer

The 6 Best Recumbent Exercise Bikes in 2025, According to Certified Trainers

Panasonic GK80 Body Groomer Review: An Innovative Tool for Managing Hair Everywhere

Cole Haan January Sale: Save Up to 63% Off Dress Sneakers, Loafers, and More

A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior

Higher radon exposure linked to increased odds of gestational diabetes

How immune cells “sniff out” pathogens

Oficiales de salud en California responden rápido a los casos de dengue

California Dengue Cases Prompt Swift Response From Public Health Officials

Best Early Black Friday Mattress Deals: Save up to 30% Off Editor-Approved Beds

Infinitopes to showcase cancer vaccine breakthroughs at SITC

The 6 Best Recumbent Exercise Bikes in 2025, According to Certified Trainers

Panasonic GK80 Body Groomer Review: An Innovative Tool for Managing Hair Everywhere

Cole Haan January Sale: Save Up to 63% Off Dress Sneakers, Loafers, and More

A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior

Higher radon exposure linked to increased odds of gestational diabetes

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories